SPARFLOZACIN, 5 MCG, SENSI-DISC— 510(k) K970385

Substantially Equivalent

Becton Dickinson Microbiology Systems

FDA 510(k) clearance K970385 for SPARFLOZACIN, 5 MCG, SENSI-DISC, Substantially Equivalent on 1997-03-10. Applicant: Becton Dickinson Microbiology Systems.

Clearance details

Applicant
Becton Dickinson Microbiology Systems
Product code
Code JTN
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Cockeysville, MD, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.